54 results
424B5
LRMR
Larimar Therapeutics Inc
14 Feb 24
Prospectus supplement for primary offering
5:08pm
, unforeseen emergencies and other outbreaks of communicable diseases, including the ongoing COVID-19 pandemic and the efforts to mitigate
424B5
LRMR
Larimar Therapeutics Inc
13 Feb 24
Prospectus supplement for primary offering
4:46pm
health epidemics, unforeseen emergencies and other outbreaks of communicable diseases, including the ongoing COVID-19 pandemic and the efforts to mitigate
8-K
EX-99.2
i11xk
10 Nov 22
Larimar Therapeutics Reports Third Quarter 2022 Operating and Financial Results
7:01am
8-K
EX-99.1
gegei70f9p
10 Nov 22
Larimar Therapeutics Reports Third Quarter 2022 Operating and Financial Results
7:01am
8-K
EX-99.1
o57p lwogb
20 Oct 22
October 2022 Larimar Therapeutics Corporate Presentation
8:11am
424B5
99dnf
14 Sep 22
Prospectus supplement for primary offering
7:28am
8-K
EX-99.1
497lxnyvhb dp7gvx2
14 Sep 22
Other Events
7:05am
8-K
EX-99.2
ft5wny8n0in7bfe
14 Sep 22
Other Events
7:05am
8-K
EX-99.1
ic9ljl7fggybsbhgssyj
11 Aug 22
Larimar plans to submit a complete response to CTI-1601’s clinical hold in the third quarter of 2022
4:13pm
8-K
EX-99.2
xba5szup
11 Aug 22
Larimar plans to submit a complete response to CTI-1601’s clinical hold in the third quarter of 2022
4:13pm
8-K
EX-99.1
7cd7ip29h7hl3 41lx
12 May 22
Larimar Therapeutics Reports First Quarter 2022 Operating and Financial Results
7:12am
8-K
EX-99.2
nz29qsdzplx1nm8 o3y6
12 May 22
Larimar Therapeutics Reports First Quarter 2022 Operating and Financial Results
7:12am
8-K
EX-99.2
az18u6
25 Mar 22
Larimar Therapeutics Reports Fourth Quarter and Full Year 2021 Operating and Financial Results
7:11am